Dr Martens CEO to depart and warns of ‘worst case’ 2025 scenario
Dr Martens said there was a “range of potential outcomes” for FY25 – including a potential “worst case scenario” if sales in the US flounder.
The announcement comes as Dr Martens files its Q4 results, in which it said FY24 was to be “in line with expectations” and that there was a “range of potential outcomes” for FY25 – including a potential “worst case scenario” if sales in the US flounder.
Already have an account? Sign in here
